REQUEST A DEMO
Total
USD $0.00
Search more companies

Ferring Pharmaceuticals Private Limited (India)

Main Activities: Management Consulting Services
Full name: Ferring Pharmaceuticals Private Limited Profile Updated: November 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Ferring Pharmaceuticals Private Limited is an unlisted company, incorporated on 04/07/1997. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U74140MH1997FTC109220 and registration number is 109220.

Headquarters
509 & 510 A-Wing 5Th Floor The Capital Plot No. C-70 Block G Bandra Kurla Complex Mumbai In 400051
Mumbai; Maharashtra; Postal Code: 400051

Contact Details: Purchase the Ferring Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Ferring Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Ferring Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Ferring Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
July 04, 1997
Key Executives
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
99.99%
Company Performance
Financial values in the chart are available after Ferring Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
11.53%
Total operating revenue
10.99%
Operating profit (EBIT)
265.69%
EBITDA
218.47%
Net Profit (Loss) for the Period
237.84%
Total assets
-3.15%
Total equity
29.35%
Operating Profit Margin (ROS)
16.08%
Net Profit Margin
10.77%
Return on Equity (ROE)
14%
Quick Ratio
1%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?